Home › Premarket Biotech Digest: Gilead HIV, Eliquis Trial Errors, Clinical Trial Phases
 

Keywords :   


Premarket Biotech Digest: Gilead HIV, Eliquis Trial Errors, Clinical Trial Phases

2015-08-04 07:51:25| Biotech - Topix.net

This may be FDA 101 for some people, but many lay investors may not be aware of the precise details; so I am providing this brief note following the FDA itself. All new drugs and almost all drugs applying for new indications must go through a clinical research where it is tested in human subjects prior to FDA approval.

Tags: trial errors clinical digest

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.05Rabanne Beauty Brings the Drama with New Lipstick
07.05Biotech Skincare Brand Mother Science Launches Retinol Synergist
07.05Nintendo breaks silence on new console... sort of
07.05Farm Progress America, May 7, 2024
07.05Farm Progress America, May 7, 2024
07.05House buyers still face 'significant' cost pressures
07.05Walking the Talk: How the Waste Industry Must Turn Sustainability Strategies into Action
07.05Boeing crewed space launch postponed for safety check
More »